Brendan Clark

8PUBLICATIONS
12CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical virologyPharmacogenomicsPsycholinguistics (incl. speech production and comprehension)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2026
Clinical and Economic Burden Following Percutaneous Coronary Intervention for STEMI: A US Real-World Evidence Study.

|Oct 01, 2025
Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL.

Sanjay Sethi, Brendan Clark, Erin K Buysman

|Sep 19, 2025
Obesity Medication Treatment Perspectives Among People with Overweight or Obesity.

John W Ostrominski, Anindit Chhibber, Effie L Kuti

|Feb 19, 2025
Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US.

Asif Shaikh, John Ritz, Julian Casciano

|Nov 07, 2023
Fanconi Syndrome in Patients With Human Immunodeficiency Virus Treated With Tenofovir-Based Antiretroviral Therapy: A Systematic Literature Review.

Mrinmayee Joshi, Brendan Clark, Todd A Lee

|May 08, 2023
Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History.

Sanjay Sethi, Brendan Clark, Lindsay G S Bengtson

Pageof 2

Frequent Collaborators

3 joint publications

Bonnie M K Donato

3 joint publications

Sanjay Sethi

2 joint publications

Asif Shaikh

1 joint publications

Jill A Ohar